Listeria-based adjuvants
US-10064898-B2 · Sep 4, 2018 · US
This page is not indexed by search engines while we improve data quality.
Advaxis Inc — Cross-Sectional Technologies
Advaxis Inc holds 3 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Advaxis Inc |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 3 |
| Recent patents in slice | 0 |
| First year | 2016 |
| Last year | 2018 |
Representative patents
Notable publications linking Advaxis Inc to Cross-Sectional Technologies.
Recombinant listeria strain expressing heterologous antigen fusion proteins and methods of use thereof
US-2017246273-A1 · Aug 31, 2017 · US
Listeria-based adjuvants
US-2016324903-A1 · Nov 10, 2016 · US
Recent filings
Latest patents from Advaxis Inc in Cross-Sectional Technologies.
Listeria-based adjuvants
US-10064898-B2 · Sep 4, 2018 · US
Recombinant listeria strain expressing heterologous antigen fusion proteins and methods of use thereof
US-2017246273-A1 · Aug 31, 2017 · US
Listeria-based adjuvants
US-2016324903-A1 · Nov 10, 2016 · US
Related pages
Navigate to parent entity pages.